The Journal of Community and Supportive OncologyEntering an era of intelligent combination therapy in cancerDecember 14, 2015Breast CancerLymphoma & Plasma Cell DisordersMelanomaImmunotherapy
The Journal of Community and Supportive OncologyDinutuximab combination therapy becomes first approval for high-risk neuroblastomaOctober 19, 2015GastroenterologyImmunotherapyGastrointestinal Cancer
The Journal of Community and Supportive OncologyNivolumab: first immunotherapy approved for lung cancerSeptember 23, 2015Lung CancerImmunotherapy
The Journal of Community and Supportive OncologyHarnessing new data on immunotherapiesJuly 22, 2015Breast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaPreventive Care
The Journal of Community and Supportive OncologyOncogenic drivers and immunotherapy: staying one step ahead of lung cancerJuly 22, 2015Lung CancerImmunotherapy
The Journal of Community and Supportive OncologyASCO 2015: from data and learning, to daily practiceJuly 22, 2015Breast CancerGastroenterologyHead & Neck/Thyroid CancersGenitourinary CancerLung CancerPreventive CareMelanoma
The Journal of Community and Supportive OncologyImmunotherapy moves into the breast cancer landscapeJanuary 16, 2015Breast CancerImmunotherapy
